Dynorphin A inhibits NMDA receptors through a pH-dependent mechanism

Molecular and Cellular Neuroscience

Volumn 24, Issue 3, 2003, Pages 525-537

  Kanemitsu, Yoshio ^a   Hosoi, Masako ^a   Zhu, Ping Jun ^a   Weight, Forrest F ^a   Peoples, Robert W ^a   McLaughlin, Joseph S ^a   Zhang, Li ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DITHIOTHREITOL; DYNORPHIN A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTON; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; EMBRYO; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR BIOLOGY; NONHUMAN; OOCYTE; OXIDATION REDUCTION REACTION; PEPTIDE MAPPING; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; XENOPUS;

EID: 0345599900     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00214-8     Document Type: Article

References (54)

1. Allen G.V., Cheung R.T., Cechetto D.F. Neurochemical changes following occlusion of the middle cerebral artery in rats. Neuroscience. 68:1995;1037-1050.
2. Andrews B.T., McIntosh T.K., Gonzales M.F., Weinstein P.R., Faden A.I. Levels of endogenous opioids and effects of an opiate antagonist during regional cerebal ischemia in rats. J. Pharmacol. Exp. Ther. 247:1988;1248-1254.
3. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:1995;3328-3341.
4. Bakshi R., Faden A.I. Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects. Neurosci. Lett. 110:1990;113-117.
5. Baskin D.S., Hosobuchi Y., Loh H.H., Lee N.M. Dynorphin(1-13) improves survival in cats with focal cerebral ischaemia. Nature. 312:1984;551-552.
6. Brauneis U., Oz M., Peoples R.W., Weight F.F., Zhang L. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin. J. Pharmacol. Exp. Ther. 279:1996;1063-1068.
7. Caudle R.M., Isaac L. Influence of dynorphin (1-13) on spinal reflexes in the rat. J. Pharmacol. Exp. Ther. 246:1988;508-513.
8. Caudle R.M., Dubner R. Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus. Neuropeptides. 32:1998;87-95.
9. Chavkin C., Goldstein A. Specific receptor for the opioid peptide dynorphin structure-activity relationships . Proc. Natl. Acad. Sci. USA. 78:1981;6543-6547.
10. Chen L., Gu Y., Huang L.Y. The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J. Neurosci. 15:1995;4602-4611.
11. Chen L., Gu Y., Huang L.Y. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J. Physiol. 482:1995;575-581.
12. Chen L., Huang L.Y. Dynorphin block of N-methyl-D-aspartate channels increases with the peptide length. J. Pharmacol. Exp. Ther. 284:1998;826-831.
13. Cheung R.T., Diab T., Cechetto D.F. Time-course of neuropeptide changes in peri-ischemic zone and amygdala following focal ischemia in rats. J. Comp. Neurol. 360:1995;101-120.
14. Choi D.W., Viseskul V. Opioids and non-opioid enantiomers selectively attenuate N-methyl-D-aspartate neurotoxicity on cortical neurons. Eur. J. Pharmacol. 155:1988;27-35.
15. Conner-Kerr T.A., Simmons D.R., Peterson G.M., Terrian D.M. Evidence for the corelease of dynorphin and glutamate from rat hippocampal mossy fiber terminals. J. Neurochem. 61:1993;627-636.
16. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51:1999;7-61.
17. 3H]CGP-39653 binding to rat brain membranes. Eur. J. Pharmacol. 271:1994;241-244.
18. Goldstein A., Ghazarossian V.E. Immunoreactive dynorphin in pituitary and brain. Proc. Natl. Acad. Sci. USA. 77:1980;6207-6210.
19. Goldstein A., Schulz R. Morphine-tolerant longitudinal muscle strip from guinea-pig ileum. Br. J. Pharmacol. 48:1973;655-666.
20. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
21. Hollt V., Haarmann I., Bovermann K., Jerlicz M., Herz A. Dynorphin-related immunoreactive peptides in rat brain and pituitary. Neurosci. Lett. 18:1980;149-153.
22. Hong J.S., Yoshikawa K., Kanamatsu T., McGinty J.F., Mitchell C.L., Sabol S.L. Repeated electroconvulsive shocks alter the biosynthesis of enkephalin and concentration of dynorphin in the rat brain. Neuropeptides. 5:1985;557-560.
23. 1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay. J. Pharmacol. Exp. Ther. 273:1995;802-807.
24. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice. Eur. J. Pharmacol. 234:1993;9-15.
25. Kanemitsu Y., Hosoi M., Zhu P., Weight F.F., McLaughlin J.S., Zhang L. Inhibition of NMDA receptor function by dynorphin A is dependent on extracellular pH. Soc. Neurosci. Abstr. 28:2000;640.18.
26. Kashiwagi K., Fukuchi J., Chao J., Igarashi K., Williams K. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons. Mol. Pharmacol. 49:1996;1131-1141.
27. Krupp J.J., Vissel B., Heinemann S.F., Westbrook G.L. N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron. 20:1998;317-327.
28. Lai S.L., Gu Y., Huang L.Y. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons. Neurosci. Lett. 247:1998;115-118.
29. Laughlin T.M., Larson A.A., Wilcox G.L. Mechanisms of induction of persistent nociception by dynorphin. J. Pharmacol. Exp. Ther. 299:2001;6-11.
30. Massardier D., Hunt P.F. A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor. Eur. J. Pharmacol. 170:1989;125-126.
31. Masuko T., Kashiwagi K., Kuno T., Nguyen N.D., Pahk A.J., Fukuchi J., Igarashi K., Williams K. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein . Mol. Pharmacol. 55:1999;957-969.
32. McBain C.J., Mayer M.L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74:1994;723-760.
33. McDaniel K.L., Mundy W.R., Tilson H.A. Microinjection of dynorphin into the hippocampus impairs spatial learning in rats. Pharmacol. Biochem. Behav. 35:1990;429-435.
34. Mott D.D., Doherty J.J., Zhang S., Washburn M.S., Fendley M.J., Lyuboslavsky P., Traynelis S.F., Dingledine R. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat. Neurosci. 1:1998;659-667.
35. Naqvi T., Haq W., Mathur K.B. Structure-activity relationship studies of dynorphin A and related peptides. Peptides. 19:1998;1277-1292.
36. Shukla V.K., Lemaire S. Non-opioid effects of dynorphins possible role of the NMDA receptor . Trends Pharmacol. Sci. 15:1994;420-424.
37. +] in the hippocampus during recovery from short-term, transient ischemia . J. Cereb. Blood Flow Metab. 12:1992;759-772.
38. Simonato M., Romualdi P. Dynorphin and epilepsy. Prog. Neurobiol. 50:1996;557-583.
39. Spadaccini R., Crescenzi O., Picone D., Tancredi T., Temussi P.A. Solution structure of dynorphin A (1-17) a NMR study in a cryoprotective solvent mixture at 278 K . J. Pept. Sci. 5:1999;306-312.
40. Stevens C.W., Yaksh T.L. Dynorphin A and related peptides administered intrathecally in the rat a search for putative kappa opiate receptor activity . J. Pharmacol. Exp. Ther. 238:1986;833-838.
41. Sullivan J.M., Traynelis S.F., Chen H.S., Escobar W., Heinemann S.F., Lipton S.A. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron. 13:1994;929-936.
42. Svingos A.L., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin . J. Neurosci. 16:1996;4162-4173.
43. Tang L.H., Aizenman E. The modulation of N-methyl-D-aspartate receptors by redox and alkylating reagents in rat cortical neurones in vitro. J. Physiol. 465:1993;303-323.
44. Tang Q., Lynch R.M., Porreca F., Lai J. Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism. J. Neurophysiol. 83:2000;2610-2615.
45. Tan-No K., Cebers G., Yakovleva T., Hoon Goh B., Gileva I., Reznikov K., Aguilar-Santelises M., Hauser K.F., Terenius L., Bakalkin G. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms. Exp. Cell. Res. 269:2001;54-63.
46. Tessmer M.R., Kallick D.A. NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles. Biochemistry. 36:1997;1971-1981.
47. Traynelis S.F., Hartley M., Heinemann S.F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science. 268:1995;873-876.
48. Traynelis S.F., Burgess M.F., Zheng F., Lyuboslavsky P., Powers J.L. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J. Neurosci. 18:1998;6163-6175.
49. Walker J.M., Moises H.C., Friederich M.W. A review of some nonopioid actions of dynorphin. Prog. Clin. Biol. Res. 192:1985;309-312.
50. Weisskopf M.G., Zalutsky R.A., Nicoll R.A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature. 365:1993;188.
51. Zhang Z., Li F., Ren M., Liu J. Effects of dynorphin A (1-17) on motor function and spinal intracellular messenger systems in rat. Chin. Med. Sci. J. 11:1996;63-68.
52. Zhang L., Peoples R.W., Oz M., Harvey-White J., Weight F.F., Brauneis U. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations. J. Neurophysiol. 78:1997;582-590.
53. Zhang L., Zheng X., Paupard M.C., Wang A.P., Santchi L., Friedman L.K., Zukin R.S., Bennett M.V. Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition. Proc. Natl. Acad. Sci. USA. 91:1994;10883-10887.
54. 2+ potentiation of recombinant NMDA receptors. Neuron. 12:1994;811-818.